Nucleolin inhibitor GroA triggers reduction in epidermal growth factor receptor activation: Pharmacological implication for glial scarring after spinal cord injury

Yona Goldshmit, Sari Schokoroy Trangle, Fabian Afergan, Tal Iram, Ronit Pinkas-Kramarski

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nucleolin inhibitor GroA triggers reduction in epidermal growth factor receptor activation: Pharmacological implication for glial scarring after spinal cord injury'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry